Latest filing published 19 Dec 2025 for AstraZeneca PLC.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Philip Broadley: trading record in brief
This profile gathers the share dealings of Philip Broadley in AstraZeneca PLC. Over a trading history stretching from 27 July 2017 to 17 December 2025, the count stands at 6 filings.
The open-market record is one-sided, with 5 purchases worth €278k and not one sale. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €72k. Clusters matter here: 2 out of 5 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 19 December 2025, the filings show a transaction in AstraZeneca PLC. The last purchase on record was published on 13 November 2024, which is 726 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Philip Broadley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,735 shares0Outside a trading venueISIN GB0009895292RNS:b1f89928-ed45-4270-b9a9-b03b2c441316-0
- 0LONISIN GB0009895292RNS:5428853Canonical exit: 11 Feb 2025 (T+90)
- 1,310 shares@ £76.25100.0% of flowXLONISIN GB0009895292FCA-NSM:3817536-0Canonical exit: 16 Mar 2021 (T+90)
- 520 shares@ £57.3814.2% of flowXLONISIN GB0009895292FCA-NSM:LSE20190501120001_14059493_20200326185143225_29019-1Canonical exit: 29 Jul 2019 (T+90)
- 415 shares@ £48.46366.1% of flowXLONISIN GB0009895292FCA-NSM:LSE20180205140001_13521913_20200330111413653_24056Canonical exit: 3 May 2018 (T+90)
- 2,300 shares@ £42.8231.0% of flowXLONISIN GB0009895292FCA-NSM:LSE20170728110001_13311399_20200330131519816_20391-1Canonical exit: 25 Oct 2017 (T+90)
6 of 6 declarations
